MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Life-Threatening immune storms
Disease control CompletedThis study tested a drug called emapalumab in children and adults with a dangerous immune system overreaction called Macrophage Activation Syndrome (MAS). MAS can occur in people with Still's disease or lupus who don't respond well to high-dose steroid treatment. The trial aimed …
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists probe deadly immune storm in sepsis patients
Knowledge-focused CompletedThis study aimed to understand why some sepsis patients develop a dangerous immune system overreaction called macrophage activation syndrome, which has a high death rate. Researchers compared blood samples from 27 intensive care patients with this condition to those with regular …
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC